Feed 6919.TW
69
Caliway Biopharmaceuticals Co. L
6919.TW · TAI
$110.50 +2.31% (+$2.50)
1M +0.47%
Market Cap $169.6B
P/E Ratio -
Div. Yield -
ROE -
Valuation
0 /100
Expensive P/B 565.71x
P/S 4,466.95x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 36.38%
Rev. growth 43.59%
FCF growth N/A
Profitability
20 /100
Weak Net margin 925.20%
Op. margin 1,859.31%
FCF margin 1,166.64%
Quality
2 /100
Poor ROA 116.38%
Asset turnover 0.13x
ROIC 234.94%
Debt
69 /100
Low Current ratio 109.71x
Int. coverage -4,534.35x
Debt/Equity 0.00x
Stability
29 /100
Unstable Rev. volatility 118.22%
EPS volatility 53.26%
Profitable years 0
Vprašajte StockBota o 6919.TW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Vivian Ling
Employees
20
Headquarters
New Taipei City
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report